T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice

Abstract IL-2Rα, in part, comprises the high affinity receptor for IL-2, a cytokine important in immune proliferation, activation, and regulation. IL-2Rα deficient mice (IL-2Rα-KO) develop systemic autoimmune disease and die from severe anemia between 18 and 80 days of age. These mice develop kineti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Genevieve N. Mullins, Kristen M. Valentine, Mufadhal Al-Kuhlani, Dan Davini, Kirk D. C. Jensen, Katrina K. Hoyer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8b5b676dfc164f7eb4056f8dcb9d590f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8b5b676dfc164f7eb4056f8dcb9d590f
record_format dspace
spelling oai:doaj.org-article:8b5b676dfc164f7eb4056f8dcb9d590f2021-12-02T13:34:00ZT cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice10.1038/s41598-020-78975-y2045-2322https://doaj.org/article/8b5b676dfc164f7eb4056f8dcb9d590f2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-78975-yhttps://doaj.org/toc/2045-2322Abstract IL-2Rα, in part, comprises the high affinity receptor for IL-2, a cytokine important in immune proliferation, activation, and regulation. IL-2Rα deficient mice (IL-2Rα-KO) develop systemic autoimmune disease and die from severe anemia between 18 and 80 days of age. These mice develop kinetically distinct autoimmune progression, with approximately a quarter dying by 21 days of age and half dying after 30 days. This research aims to define immune parameters and cytokine signaling that distinguish cohorts of IL-2Rα-KO mice that develop early- versus late-stage autoimmune disease. To investigate these differences, we evaluated complete blood counts (CBC), antibody binding of RBCs, T cell numbers and activation, hematopoietic progenitor changes, and signaling kinetics, during autoimmune hemolytic anemia (AIHA) and bone marrow failure. We identified several alterations that, when combined, correlate to disease kinetics. Early onset disease correlates with anti-RBC antibodies, lower hematocrit, and reduced IL-7 signaling. CD8 regulatory T cells (Tregs) have enhanced apoptosis in early disease. Further, early and late end stage disease, while largely similar, had several differences suggesting distinct mechanisms drive autoimmune disease kinetics. Therefore, IL-2Rα-KO disease pathology rates, driven by T cell signaling, promote effector T cell activation and expansion and Treg dysfunction.Genevieve N. MullinsKristen M. ValentineMufadhal Al-KuhlaniDan DaviniKirk D. C. JensenKatrina K. HoyerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-16 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Genevieve N. Mullins
Kristen M. Valentine
Mufadhal Al-Kuhlani
Dan Davini
Kirk D. C. Jensen
Katrina K. Hoyer
T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice
description Abstract IL-2Rα, in part, comprises the high affinity receptor for IL-2, a cytokine important in immune proliferation, activation, and regulation. IL-2Rα deficient mice (IL-2Rα-KO) develop systemic autoimmune disease and die from severe anemia between 18 and 80 days of age. These mice develop kinetically distinct autoimmune progression, with approximately a quarter dying by 21 days of age and half dying after 30 days. This research aims to define immune parameters and cytokine signaling that distinguish cohorts of IL-2Rα-KO mice that develop early- versus late-stage autoimmune disease. To investigate these differences, we evaluated complete blood counts (CBC), antibody binding of RBCs, T cell numbers and activation, hematopoietic progenitor changes, and signaling kinetics, during autoimmune hemolytic anemia (AIHA) and bone marrow failure. We identified several alterations that, when combined, correlate to disease kinetics. Early onset disease correlates with anti-RBC antibodies, lower hematocrit, and reduced IL-7 signaling. CD8 regulatory T cells (Tregs) have enhanced apoptosis in early disease. Further, early and late end stage disease, while largely similar, had several differences suggesting distinct mechanisms drive autoimmune disease kinetics. Therefore, IL-2Rα-KO disease pathology rates, driven by T cell signaling, promote effector T cell activation and expansion and Treg dysfunction.
format article
author Genevieve N. Mullins
Kristen M. Valentine
Mufadhal Al-Kuhlani
Dan Davini
Kirk D. C. Jensen
Katrina K. Hoyer
author_facet Genevieve N. Mullins
Kristen M. Valentine
Mufadhal Al-Kuhlani
Dan Davini
Kirk D. C. Jensen
Katrina K. Hoyer
author_sort Genevieve N. Mullins
title T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice
title_short T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice
title_full T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice
title_fullStr T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice
title_full_unstemmed T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice
title_sort t cell signaling and treg dysfunction correlate to disease kinetics in il-2rα-ko autoimmune mice
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/8b5b676dfc164f7eb4056f8dcb9d590f
work_keys_str_mv AT genevievenmullins tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice
AT kristenmvalentine tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice
AT mufadhalalkuhlani tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice
AT dandavini tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice
AT kirkdcjensen tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice
AT katrinakhoyer tcellsignalingandtregdysfunctioncorrelatetodiseasekineticsinil2rakoautoimmunemice
_version_ 1718392806885556224